Thoracic Aortic Stent Grafts (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
This Medical Devices sector report, “Thoracic Aortic Stent Grafts (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. One unit of thoracic aortic stent graft refers to a single main component (main proximal component) with no extensions.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The report enables you to -
Summary
This Medical Devices sector report, “Thoracic Aortic Stent Grafts (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Thoracic Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Thoracic aortic stent grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. One unit of thoracic aortic stent graft refers to a single main component (main proximal component) with no extensions.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Thoracic Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies
5 Thoracic Aortic Stent Grafts Companies and Product Overview
6 Thoracic Aortic Stent Grafts- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- APT Medical Inc
- Beijing Tianzhu Ruichang Medical Technology Co Ltd
- EndoSpan Ltd
- Evasc Medical Systems Corp
- Hangzhou Endonom Medtech Co Ltd
- JOTEC GmbH
- Lombard Medical Technologies Inc.
- Lundquist
- Medtronic Plc
- MicroPort Endovascular (Shanghai) Co., Ltd.
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- St. Jude Medical LLC
- Terumo Aortic
- TriVascular Inc
- W. L. Gore & Associates Inc
- Zylox-Tonbridge Medical Technology Co Ltd
